To find out if receiving standard chemotherapy (doxorubicin and trabectedin) can extend the cancer-free survival of patients with Stage 1b/2 uterine leiomyosar…

Uterine Leiomyosarcoma

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07076186

Phase 2

A Randomized Phase II Study of Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

This is a clinical trial to test letrozole in patients with uterine leiomyosarcoma. The main question is will treatment with letrozole extend progression-free …

Uterine Leiomyosarcoma

~Estimated

~$10 – $6,250

GOG FoundationNCT05649956

Phase 2

A Phase 2 Study Evaluating the Efficacy of Elacestrant in Patients With Estrogen Receptor Positive Uterine Sarcomas

This study is to evaluate the efficacy and safety of elacestrant, in participants with advanced estrogen receptor (ER)-positive uterine sarcomas. The name of t…

Uterine SarcomaUterine LeiomyosarcomaEndometrial Stromal Sarcoma+6 more

~Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT07467772